Meissner PE et al., 2006-10-08: Burkina Faso 2004 uncontrolled dose-finding study of methylene blue plus chloroquine in 435 young children with uncomplicated falciparum malaria, reporting three serious adverse events (one probably attributable to study medication) and day-14 failure around 10%.
In 2004, an uncontrolled dose-finding study on the combination MB-CQ was performed in 435 young children with uncomplicated falciparum malaria in Burkina Faso
84
Meissner PE et al., 2006-10-08: Burkina Faso 2004 uncontrolled dose-finding study of methylene blue plus chloroquine in 435 young children with uncomplicated falciparum malaria, reporting three serious adverse events (one probably attributable to study medication) and day-14 failure around 10%. C9 Burkina Faso (Malar J 5:84, 2006). Study type: uncontrolled dose-finding study, N=435 children. Oral methylene blue plus chloroquine; doses in the paper (not in abstract captured). Comparator: none (uncontrolled); chloroquine monotherapy had >50% clinical failure in the area in 2003, cited as context. Funder/conflicts not stated. Bearing PARTLY: dose-finding without a control arm, plus a probable drug-attributed serious adverse event. Also filed as MTL-002 (claims C1, C9). Study type: uncontrolled series.
